Ruchita Sinha is a Senior Partner at ARTIS Ventures with a background spanning science, corporate strategy at Pfizer, and over a decade in venture capital. She focuses on the convergence of biology, healthcare, data, and AI. She earned her MBA from The University of Chicago Booth School of Business and has been involved with over 30 startups.
Her interest in healthcare was initially sparked by her mothers wish for her to become a doctor. While she pursued research instead, she retains a sharp inquisitiveness, a skill she humorously notes comes in handy with her pre-teen children. She is also a vocal advocate for increasing diversity within the venture capital industry.
Unique fact: During her graduate studies, she built virus particles with the envelope of an Ebola virus and the genome of a retrovirus to safely study its transmission.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.